The basis of persistent bacterial infections

Trends in Microbiology

Volumn 11, Issue 2, 2003, Pages 80-86

  Rhen, Mikael ^a   Eriksson, Sofia ^a   Clements, Mark ^b   Bergström, Sven ^c   Normark, Staffan J ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENIC MODULATION; ANTIGENIC VARIATION; ANTIMICROBIAL ACTIVITY; BACTERIAL INFECTION; COMPLEMENT ACTIVATION; HELICOBACTER PYLORI; HOST CELL; HOST PATHOGEN INTERACTION; HOST RESISTANCE; MAMMAL; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOGENESIS; PHYLOGENY; PRIORITY JOURNAL; REVIEW;

ACTINOBACTERIA (CLASS); BACTERIA (MICROORGANISMS); HELICOBACTER; HELICOBACTER PYLORI; MAMMALIA; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; UNCULTURED ACTINOMYCETE;

EID: 0037321598     PISSN: 0966842X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-842X(02)00038-0     Document Type: Review

References (58)

1. Niedobitek G., et al. Epstein-Barr virus infection and human malignancies. Int. J. Exp. Pathol. 82:2001;149-170.
2. Dye C., et al. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA. 282:1999;677-686.
3. House D., et al. Typhoid fever: pathogenesis and disease. Curr. Opin. Infect. Dis. 14:2001;573-578.
4. Rothenbacher D., et al. Role of parents in transmission of Helicobacter pylori to their children. Pediatr. Infect. Dis. 21:2002;674-679.
5. Covacci A., et al. Helicobacter pylori virulence and genetic geography. Science. 284:1999;1328-1333.
6. Eslick G.D., et al. Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am. J. Gastroenterol. 94:1999;2373-2379.
7. Shukla V.K., et al. Carcinoma of the gallbladder - is it a sequale of typhoid? Dig. Dis. Sci. 45:2000;900-903.
8. Olfat F.O., et al. Cultured human gastric explants: a model for studies of bacteria-host interaction during conditions of experimental Helicobacter pylori infection. J. Infect. Dis. 186:2002;423-427.
9. Suda Y., et al. Chemical structure and biological activity of a lipid A component from Helicobacter pylori strain 206. J. Endotoxin Res. 7:2001;95-104.
10. Kawahara T., et al. Type I Helicobacter pylori lipopolysaccharide stimulates toll-like receptor 4 and activates mitogen oxidase 1 in gastric pit cells. Infect. Immun. 69:2001;4382-4389.
11. Odenbreit S., et al. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science. 287:2000;1497-1500.
12. Fischer W., et al. Systematic mutagenesis of the Helicobacter pylori cag pathogenicity island: essential genes for CagA translocation in host cells and induction of interleukin-8. Mol. Microbiol. 42:2001;1337-1348.
13. Su B., et al. Signal transduction-mediated adherence and entry of Helicobacter pylori into cultured cells. Gastroenterology. 117:1999;595-604.
14. Gobert A.P., et al. Cutting edge: Urease release by Helicobacter pylori stimulates macrophage inducible nitric oxide synthase. J. Immunol. 168:2002;6002-6006.
15. Mahdavi J., et al. Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation. Science. 297:2002;573-578.
16. Hsu P.I., et al. Clinical presentation in relation to diversity within the Helicobacter pylori cag pathogenicity island. Am. J. Gastroenterol. 97:2002;2231-2238.
17. Björkholm B., et al. Helicobacter pylori entry into human gastric epithelial cells: a potential determinant of virulence, persistence, and treatment failures. Helicobacter. 5:2000;148-154.
18. Waidner B., et al. Essential role of ferritin Pfr in Helicobacter pylori iron metabolism and gastric colonization. Infect. Immun. 70:2002;3923-3929.
19. Barbour A.G. Antigenic variation by relapsing fever Borrelia species and other bacterial pathogens. Craig N.L., et al. Mobile DNA II. 2002;972-996 ASM Press.
20. Shamaei-Tousi A., et al. Erythrocyte-aggregating relapsing fever spirochete Borrelia crocidurae induces formation of microemboli. J. Infect. Dis. 180:1999;1929-1938.
21. Shamaei-Tousi A., et al. Testicular damage by microcirculatory disruption and colonization of an immune priviliged site during Borrelia crocidurae infection. J. Exp. Med. 193:2001;995-1004.
22. Gilmore R.D. Jr, et al. Analysis of Borrelia burgdorferi gene expression during life cycle phases of the tick vector Ixodes scapularis. Microbes Infect. 3:2001;799-808.
23. Pal U., et al. Attachment of Borrelia burgdorferi within Ixodes scapularis mediated by outer surface protein A. J. Clin. Invest. 106:2000;561-569.
24. de Silva A.M., Fikrig E. Arthropod- and host-specific gene expression by Borrelia burgdorferi. J. Clin. Invest. 99:1997;377-379.
25. Liang F.T., et al. Molecular adaptation of Borrelia burgdorferi in the murine host. J. Exp. Med. 196:2002;275-280.
26. Zhang J.R., et al. Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence cassettes. Cell. 89:1997;275-285.
27. Nordstrand A., et al. Borrelia pathogenesis research in the post-genomic and post-vaccine era. Curr. Opin. Microbiol. 3:2000;86-92.
28. Hellwage J., et al. The complement regulator factor H binds to the surface protein OspE of Borrelia burgdorferi. J. Biol. Chem. 276:2001;8427-8435.
29. McKinney J.D., et al. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase. Nature. 406:2000;683-685.
30. Glickman M.S., et al. A novel mycolic acid cyclopropane synthetase is required for coding, persistence and virulence of Mycobacterium. Mol. Cell. 5:2000;717-727.
31. Hong P.C., et al. Identification of genes required for chronic persistence of Brucella abortus in mice. Infect. Immun. 68:2000;4102-4107.
32. Glickman M.S., Jacobs W.R. Jr. Microbial pathogenesis of Mycobacterium tuberculosis: dawn of a discipline. Cell. 104:2001;477-485.
33. Fritz C., et al. Dependence of Mycobacterium bovis BCG on anaerobic nitrate reductase for persistence is tissue specific. Infect. Immun. 70:2002;289-291.
34. Lim A., et al. Oxygen depletion-induced dormancy in Mycobacterium bovis BCG. J. Bacteriol. 181:1999;2252-2256.
35. Zahrt T.C., Deretic V. Mycobacterium tuberculosis signal transduction system required for persistent infections. Proc. Natl. Acad. Sci. U. S. A. 98:2001;12706-12711.
36. Montaraz J.A., Winter J.A. Comparison of living and nonliving vaccines for Brucella abortus in BALB/c mice. Infect. Immun. 53:1986;245-251.
37. Ugalde R.A. Intracellular life style of Brucella spp. Common genes with other animal pathogens, plant pathogens, and endosymbionts. Microbes Infect. 1:1999;1211-1219.
38. LeVier K., et al. Similar requirements of a plant symbiont and a mammalian pathogen for prolonged intracellular survival. Science. 287:2000;2492-2493.
39. Wayne L.G., Lin K.Y. Glyoxylate metabolism and adaptation of Mycobacterium tuberculosis to survival under anaerobic conditions. Infect. Immun. 37:1982;1042-1049.
40. Anderson G.W., et al. Typhoid carriers. A study of their disease producing potentialities over a series of years as indicated by a study of cases. Am. J. Public Health. 26:1936;396-405.
41. Edelman R., Levine M. Summary of an international workshop on typhoid fever. Rev. Infect. Dis. 8:1986;329-349.
42. Yamamoto T., et al. Disruption of the genes for ClpXP protease in Salmonella enterica serovar Typhimurium results in persistent infection in mice, and development of persistence requires endogenous gamma interferon and tumor necrosis factor α Infect. Immun. 69:2001;3164-3174.
43. Stocker B.A. Aromatic-dependent Salmonella as antibacterial vaccines and as presenters of heterologous antigens or of DNA encoding them. J. Biotechnol. 83:2000;45-50.
44. Sukupolvi S., et al. Development of a murine model of chronic Salmonella infection. Infect. Immun. 65:1997;838-842.
45. Clements M.O., et al. Polynucleotide phosphorylase is a global regulator of virulence and persistency in Salmonella enterica. Proc. Natl. Acad. Sci. U. S. A. 99:2002;8784-8789.
46. Ottones F., et al. Activation of human Vγ9δ2 T cells by a Brucella suis non-peptic fraction impairs bacterial intracellular replication in monocytic infected cells. Immunology. 100:2000;252-258.
47. Ottones F., et al. Vγ9δ2 T cells impair intracellular multiplication of Brucella suis in autologous monocytes through soluble factor release and contact-dependent cytotoxic effect. J. Immunol. 165:2000;7133-7139.
48. Louanguy E., et al. IL-12 and IFN-γ in host defence against mycobacteria and Salmonella in mice and men. Curr. Opin. Immunol. 11:1999;346-351.
49. Ehler S., Richter E. Differential requirement for interferon-γ to restrict the growth of or eliminate some recently identified species of nontuberculous mycobacteria. Clin. Exp. Immunol. 124:2001;229-238.
50. Flynn J.L., et al. Effects of aminoguanidine on latent murine tuberculosis. J. Immunol. 160:1998;1796-1803.
51. Garvis S.G., et al. A role for the PhoP/PhoQ regulon in inhibition of fusion between lysosomes and Salmonella-containing vacuoles in macrophages. Cell. Microbiol. 3:2001;731-744.
52. Flynn J.L., Chan L. Immunology of tuberculosis. Annu. Rev. Immunol. 19:2001;93-129.
53. Flynn J.L., Ernst J.D. Immune responses in tuberculosis. Curr. Opin. Immunol. 12:2000;432-436.
54. Hess J., et al. Salmonella typhimurium aroA- infection in gene-targeted immunodeficient mice. J. Immunol. 156:1996;3321-3326.
55. Ottenhoff T.H., et al. Genetics, cytokines and human infectious disease: lessons from weakly pathogenic mycobacteria and salmonellae. Nat. Genet. 32:2002;97-105.
56. Redpath S., et al. Hijacking and exploitation of IL-10 by intracellular pathogens. Trends Microbiol. 9:2001;86-92.
57. Moody D.B., et al. CD1d-mediated T cell recognition of a glycolipid antigen generated from mycobacterial lipid and host carbohydrate during infection. J. Exp. Med. 192:2000;965-976.
58. Amieva M.R., et al. Helicobacter pylori enter and survive within multivesicular vacuoles of epithelial cells. Cell. Microbiol. 4:2002;677-690.